FSIS and FDA to host a public meeting to discuss the interagency retail Listeria monocytogenes risk assessment on June 23 in Washington, DC, to discuss the background, approach and scope of a new interagency risk assessment.
FSIS and FDA to host a public meeting to discuss the interagency retail Listeria monocytogenes risk assessment on June 23 in Washington, DC, to discuss the background, approach and scope of a new interagency risk assessment.
